TNFSF13 and cervical carcinoma: For immunostimulator, SLC30A10 expression was correlated with TNFRSF25 (Spearman: ρ = 0.202, P = 0.00038), TNFSF13 (Spearman: ρ = -0.193, P = 0.000703), TNFRSF13C (Spearman: ρ = -0.209, P = 0.000245), and RAET1E (Spearman: ρ = 0.197, P = 0.000546) in cervical carcinoma (Figure 8C-8D).